Qinglian Wen

发表

Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy

JingBo Wu, S. Imani, M. Maghsoudloo, 2022, Annals of medicine.

Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy

S. Imani, Marzieh Dehghan Shasaltaneh, Qinglian Wen, 2022, Frontiers in Oncology.

A novel radio-sensitization method for lung cancer therapy: enhanced radiosensitization induced by antigens/antibodies reaction after targeting tumor hypoxia using Bifidobacterium

JingBo Wu, S. Fu, Yi Li, 2020 .

Therapeutic targeting of VEGF and/or TGF-β to enhance anti-PD-(L)1 therapy: The evidence from clinical trials

Linwei Li, Rui-lin Ding, Qinglian Wen, 2022, Frontiers in Oncology.

5-Fluorouracil combined with cisplatin via arterial induction for advanced T-stage nasopharyngeal carcinoma: A 10-year outcome of a phase I/II study

JingBo Wu, P. Ren, Sheng Lin, 2022, Frontiers in Oncology.

In situ administration of temperature-sensitive hydrogel composite loading paclitaxel microspheres and cisplatin for the treatment of melanoma.

S. Fu, Ling Zhao, Jie Dai, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Ef ﬁ cacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b Study

He-long Zhang, Baolan Li, Yu-Mei Shi, 2022 .

Bacteria-Driven Tumor Microenvironment-Sensitive Nanoparticles Targeting Hypoxic Regions Enhances the Chemotherapy Outcome of Lung Cancer

S. Fu, Q. Wen, Jie Dai, 2023, International journal of nanomedicine.

Diffuse Large B-Cell Lymphoma Infiltrating Limb Bones With a Few Lymphadenopathy Revealed on Whole-Body 18F-FDG PET/CT.

Yue Chen, Qinglian Wen, Yan Zhu, 2015, Clinical nuclear medicine.

Successful Treatment of a Patient With Brain Metastasis From Ovarian Cancer With BRCA Wild Type Using Niraparib: A Case Report and Review of the Literature

Zhen-hua Zhang, Dan Li, Wenfeng He, 2022, Frontiers in Oncology.

Zinc finger and SCAN domain-containing protein 18 is a potential DNA methylation-modified tumor suppressor and biomarker in breast cancer

S. Fu, Yu Fan, Yuhao Luo, 2023, Frontiers in Endocrinology.

Paclitaxel-loaded tumor cell-derived microparticles improve radiotherapy efficacy in triple-negative breast cancer by enhancing cell killing and stimulating immunity.

Shan Luo, Xiao-ming Hu, Qinglian Wen, 2022, International journal of pharmaceutics.

Anoikis resistance––protagonists of breast cancer cells survive and metastasize after ECM detachment

Wei Li, Zhangang Xiao, Yalan Dai, 2023, Cell Communication and Signaling.

Interstitial brachytherapy combined with PARP inhibitors in the treatment of chemoresistant recurrent epithelial ovarian cancer: A case report

Y. Bian, Zhen-hua Zhang, Dan Li, 2022, Frontiers in Oncology.

Bioactive Bacteria/MOF Hybrids Can Achieve Targeted Synergistic Chemotherapy and Chemodynamic Therapy against Breast Tumors

S. Fu, Jianmei Li, Fancai Zeng, 2023, Advanced Functional Materials.

The p110α/ΔNp63α complex mutations in triple-negative breast cancer: Potential targets for transcriptional-based therapies.

S. Imani, M. Maghsoudloo, Qinglian Wen, 2023, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.